image: CT images of two tumor lesions in the pelvis of a patient enrolled in the study (yellow arrows). The tumors regressed in size during the vaccination treatment (bottom) compared to before vaccination (top). This material relates to a paper that appeared in the 11 April, issue of Science Translational Medicine, published by AAAS. The paper, by J.L. Tanyi at University of Pennsylvania in Philadelphia, PA, and colleagues was titled, "Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer." view more
Credit: J.L. Tanyi <i>et al., Science Translational Medicine </i>(2018)